From The Editor

  1. Pharmaceutical Scientists' Salaries in 2023 1/15/2024

    The 2023 AAPS survey of pharmaceutical scientists' salaries showed a 6.7% jump over 2022, but the industry has work to do on closing the gender gap.

  2. A New Year At Life Science Leader 1/1/2024

    Life Science Leader wishes you a happy New Year and announces plans for 2024.

  3. Leadership For Tomorrow 12/1/2023

    Biopharma heavy hitters convened at the Galien Forum in New York City, offering tips and guidance for the leaders of tomorrow.

  4. Krystal Biotech's Side Business: Gene-Based Aesthetics 11/1/2023

    Krystal Biotech's side business is an aesthetics company, Jeune Aesthetics, that uses the same platform and viral vector as Krystal to deliver collagen genes to consumers seeking aesthetic improvement.

  5. A Family Affair 11/1/2023

    For Krish and Suma Krishnan, the husband-and-wife leadership team at Krystal Biotech, bringing work home, and bringing home to work, is inevitable. A larger shared goal smooths the edges. 

  6. Too Much Talk About Technology 10/2/2023

    To adopt and use new technology effectively, leaders should focus on people and their problems, not the technology itself, according to former Google executive turned biotech CEO.

  7. The L Word 9/1/2023

    As buzzy development areas buckle down to face the realities of strict regulations, financial demands, and specific unmet needs, the language leaders use to describe their efforts can help, or hurt.

  8. A Measure Of Improvement Needed 8/1/2023

    New and improved ways of measuring disease symptoms and responses to therapy must overcome established forms of measurement used for regulatory approval. 

  9. More Than A Seat At The Table 7/3/2023

    Bringing different perspectives together is important when debating industry policies, but the middle ground can still be allusive.

  10. More Transparency, To A Point 6/1/2023

    New salary transparency laws are being enacted by a growing number of states, and more transparency is needed to address existing inequities. Is it possible to be too transparent?